Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity

Overview of attention for article published in Arthritis Research & Therapy, November 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

news: 1 news outlet

policy: 1 policy source

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 102 Mendeley

Summary News Policy documents Dimensions citations

So far, Altmetric has seen 1 news story.

Impact of certolizumab pegol on patient-reported outcomes in rheumatoid arthritis and correlation with clinical measures of disease activity

Bioportfolio, 27 Nov 2015

IntroductionThe effect of certolizumab pegol (CZP) on patient-reported outcomes (PROs) was investigated in 1063 patients with…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.